{"version":"1.0","provider_name":"15\u00ba Congresso Paulista de Infectologia 2026 | S\u00e3o Paulo","provider_url":"https:\/\/infectologiapaulista.org.br\/congresso2026","author_name":"admin","author_url":"https:\/\/infectologiapaulista.org.br\/congresso2026\/author\/conseld\/","title":"Convidados Internacionais - 15\u00ba Congresso Paulista de Infectologia 2026 | S\u00e3o Paulo","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uV7u2BlKRS\"><a href=\"https:\/\/infectologiapaulista.org.br\/congresso2026\/convidados-internacionais\/\">Convidados Internacionais<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/infectologiapaulista.org.br\/congresso2026\/convidados-internacionais\/embed\/#?secret=uV7u2BlKRS\" width=\"600\" height=\"338\" title=\"&#8220;Convidados Internacionais&#8221; &#8212; 15\u00ba Congresso Paulista de Infectologia 2026 | S\u00e3o Paulo\" data-secret=\"uV7u2BlKRS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/infectologiapaulista.org.br\/congresso2026\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Convidados Internacionais Andrew Ddungu Kambugu (Uganda) Dr. Andrew Kambugu, MBChB, MMed Executive Director, Infectious Diseases Institute, Makerere University, Kampala, Uganda Dr. Andrew Kambugu is an infectious diseases physician and global health leader who has transformed the way HIV, tuberculosis, and malaria are managed across East Africa. As Executive Director of the Infectious Diseases Institute (IDI) at Makerere University, he oversees clinical research, health systems strengthening, and global health security initiatives throughout Africa and beyond. A pioneer of the clinical infectious diseases specialty in East Africa, Dr. Kambugu has published research that has advanced HIV and opportunistic infection management and directly influenced regional treatment guidelines. His leadership has also shaped Uganda&#8217;s response to emerging infectious disease threats, including the Ebola and COVID-19 outbreaks, where IDI played a critical role in surveillance, clinical management, and response coordination. Under his stewardship, IDI has expanded its clinical services, laboratory capacity, and professional training programmes, developing the next generation of infectious diseases specialists across the region. Dr. Kambugu holds an MBChB and MMed in Internal Medicine from Makerere University. He is a Fellow of the Uganda National Academy of Sciences and the Royal College of Physicians, and he serves on several regional and international scientific advisory bodies. Anton Pozniak &#8211; Londres Anton Pozniak started caring for patients with HIV in 1983 in London.\u00a0 In 1989 he did his doctorate on TB\/HIV in Zimbabwe. He is a Consultant Physician at the Chelsea and Westminster Hospital in London and was Director of the HIV service from 2008 until 2018.He was President of the International AIDS Society from 2018-2020 and President of the European AIDS Trial Network NEAT-ID from 2012-2024. He is Principal Investigator for a Test and Treat project in Tanzania He is HIV Guidelines panel member of WHO, the European AIDS Clinical Society and BHIVA. \u00a0He is a DSMB chair for MRC and PENTA studies. He has published over 450 peer-reviewed papers. He has been involved in HIV charity work in India, Africa and the UK Forma parte del Comit\u00e9 Cient\u00edfico de Neuroinfectolog\u00eda de la Sociedad Panamericana de Enfermedades Infecciosas as\u00ed como tambi\u00e9n de la Sociedad Dominicana de Infectolog\u00eda, participando activamente en el desarrollo de iniciativas acad\u00e9micas y cient\u00edficas orientadas a fortalecer la investigaci\u00f3n, la educaci\u00f3n m\u00e9dica continua y la cooperaci\u00f3n regional en el campo de la neuroinfectolog\u00eda. Su trayectoria profesional integra la excelencia asistencial, la investigaci\u00f3n y la docencia, consolid\u00e1ndose como una de las referentes de la infectolog\u00eda y la neuroinfectolog\u00eda en la Rep\u00fablica Dominicana. HEIDY ADAMES ESPINAL &#8211; Rep\u00fablica Dominicana M\u00e9dica internista e infect\u00f3loga, con Alta Especialidad en Neuroinfectolog\u00eda por la Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) y el Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda &#8220;Manuel Velasco Su\u00e1rez&#8221; (INNNMVS), Ciudad de M\u00e9xico. Es la \u00fanica especialista en Neuroinfectolog\u00eda en la Rep\u00fablica Dominicana con esta formaci\u00f3n de alta especializaci\u00f3n. Realiz\u00f3 su formaci\u00f3n en Medicina Interna en el Hospital Regional Universitario Jos\u00e9 Mar\u00eda Cabral y B\u00e1ez, Santiago, Rep\u00fablica Dominicana, y posteriormente complet\u00f3 el posgrado en Infectolog\u00eda en el Hospital Salvador B. Gautier, Santo Domingo, Rep\u00fablica Dominicana. Actualmente se desempe\u00f1a como Jefa del Departamento de Infectolog\u00eda y Control de Infecciones del Hospital Universitario Presidente Estrella Ure\u00f1a, donde lidera estrategias para la prevenci\u00f3n y el control de las infecciones asociadas a la atenci\u00f3n sanitaria, la optimizaci\u00f3n del uso de antimicrobianos y el manejo de pacientes con enfermedades infecciosas complejas. Su labor acad\u00e9mica y cient\u00edfica incluye publicaciones en revistas nacionales e internacionales, con especial inter\u00e9s en neuroinfectolog\u00eda. Adem\u00e1s es conferencista invitada en congresos cient\u00edficos nacionales e internacionales, donde comparte su experiencia en el diagn\u00f3stico y manejo de enfermedades infecciosas complejas y neuroinfecciones, contribuyendo de manera activa a la educaci\u00f3n m\u00e9dica continua y al fortalecimiento del conocimiento cient\u00edfico en Am\u00e9rica Latina. Jaime Lora-tamayo, Md, Phd ID physician with more than 20 years of clinical experience, expert in bone and joint infections, as well as foreign-body associated infection. He was trained in the ID Department of the Hospital Univ. Bellvitge (Barcelona, Spain), and is currently ID Consultant in surgical wards at the Hospital Universitario 12 de Octubre (Madrid, Spain). Associate professor at the School of Medicine, Universidad Complutense. Author of over a hundred of publications and research leader of clinical and translational projects. Member of the Group of Osteoarticular Infections (Spanish Society of Clinical Microbiology and Inf. Diseases), ESCMID Study Group of Implant-Associated Infections (European Society of Clinical Microbiology and Inf. Diseases), and Treasurer at the Anti-Infective Pharmacology Group of the International Society of Antimicrobial Chemotherapy. Laura Magnasco (it\u00e1lia) Dr. Laura Magnasco is an Infectious Diseases specialist at IRCCS AOM San Martino, Genova, Italy, where she serves as consultant for surgical and post-transplant intensive care units. She completed her specialization in 2020 with a thesis focused on multidrug-resistant bacterial pathogens and Candidozyma auris in the ICU setting. Her clinical and research interests focus on invasive fungal infections, particularly on C. auris epidemiology, infection control, and antifungal management. In the early phase of the COVID-19 pandemic, Dr. Magnasco played a key role in the hospital&#8217;s Infection Control and Prevention taskforce, taking part in the development of local screening protocols and containment strategies in response to a nosocomial C. auris outbreak. The implementation of these measures resulted in the complete elimination of new cases of colonization and infection, with no further cases recorded over the last year. Her scientific contributions to the field are reflected in more than 15 publications in peer-reviewed journals on C. auris, contributing to the study of this globally significant emerging pathogen. Paolo Ant\u00f4nio Grossi (It\u00e1lia) Born on June 12, 1956 in Bergamo, Italy Institution: University of Insubria \/ASST-Sette Laghi Department\/Division:Medicine &amp; Surgery \/ Infectious and Tropical Diseases Unit Position Title PROFESSOR OF INFECTIOUS DISEASES \u2013 DIRECTOR INFECTIOUS AND TROPICAL DISEASES UNIT AND OF THE DEPARTMENT OF RESEARCH AND CLINICAL ASPECTS OF INFECTIOUS DISEASES OF ASST- SETTE LAGHI, VARESE. DIRECTOR OF THE RESIDENCY PROGRAM ON IFECTIOUS AND TROPICAL DISEASES. Pranita Tamma (EUA) Pranita Tamma is a Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine. Her research program centers on elucidating the mechanisms underlying antimicrobial","thumbnail_url":"https:\/\/infectologiapaulista.org.br\/congresso2026\/wp-content\/uploads\/2026\/06\/ANDREW-KAMBUGU.jpg","thumbnail_width":1200,"thumbnail_height":1500}